Advertisements


Will 2018 Be Ionis Pharmaceuticals, Inc."s Best Year Yet?

Here's why 2018 could be a banner year for this pioneering biotech and its recent spinoff......»»

Category: topSource: foxnewsJan 13th, 2018

Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results

BERKELEY HEIGHTS, N.J., March 28, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) ("Cyclacel" or the "Company") a biopharmaceutical company developin.....»»

Category: earningsSource: benzingaMar 28th, 2018

Eloxx Pharmaceuticals Reports Full Year 2017 Financial and Operating Results and Provides Business Update

Company to host webcast and conference call on Tuesday, March 20, 2018 at 8 am ET Management to discuss recent data and progress on development plans WALTHAM, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. ("Eloxx") .....»»

Category: earningsSource: benzingaMar 19th, 2018

Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Operational Highlights

DEVON, Pa., March 12, 2018 (GLOBE NEW.....»»

Category: earningsSource: benzingaMar 12th, 2018

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Programs Update

Interim Analysis for Phase 3 HONOR study of Tonmya® (Cyclobenzaprine HCl Sublingual Tablets) inMilitary-Related PTSD Expected in Third Quarter of 2018; Toplin.....»»

Category: earningsSource: benzingaMar 12th, 2018

Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Results

DUBLIN, Ireland, March 08, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), "Avadel" or "t.....»»

Category: earningsSource: benzingaMar 8th, 2018

Idera Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update

EXTON, Pa. and CAMBRIDGE, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. ("Idera") (NASDAQ:IDRA), a clinical-stage b.....»»

Category: earningsSource: benzingaMar 7th, 2018

Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results, Highlights Achievements and Key 2018 Milestones

Achieved positive results of Eravacycline in Phase 3 IGNITE 4 clinical trial for cIAI  Filed NDA in US for IV Eravacycline for cIAI and PDUFA date is August 28th Raised over $65 million through unde.....»»

Category: earningsSource: benzingaMar 6th, 2018

EyeGate Pharmaceuticals Reports Full-Year 2017 Financial Results and Provides Business Update

WALTHAM, Mass., March 02, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or the "Compan.....»»

Category: earningsSource: benzingaMar 2nd, 2018

Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

BURLINGAME, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company .....»»

Category: earningsSource: benzingaMar 1st, 2018

Zomedica Pharmaceuticals Corp. Announces Year End 2017 Financial Results

ANN ARBOR, Mich., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE:ZOM) (TSX-V:ZOM) ("Zomedica" or "Company"), a veterinary diagnostic and pharmaceutical company, today reported consolidated financial results for the year e.....»»

Category: earningsSource: benzingaFeb 28th, 2018

Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides a Business Update

XERMELO® (telotristat ethyl) U.S. Net Sales Since March 2017 Launch Reach $15.1 Million Regulatory Filings for Sotagliflozin in Patients with Type 1 Diabetes Expected in First Quarter of 2018 THE WOODLANDS, Texas, Feb. 22, 2018 (GLOBE NEW.....»»

Category: earningsSource: benzingaFeb 22nd, 2018

Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update

--Ended 2017 with a healthy cash position of $380M -- --Recently announced FDA approval and launch of Glatopa® 40 mg-- CAMBRIDGE, Mass., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Mome.....»»

Category: earningsSource: benzingaFeb 21st, 2018

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2018 Ended December 31, 2017

NORTHVALE, N.J., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTC:EL.....»»

Category: earningsSource: benzingaFeb 9th, 2018

Will 2018 Be Bellicum Pharmaceuticals, Inc."s Best Year Yet?

Bellicum may disappoint investors yet again in 2018. Here's why......»»

Category: topSource: foxnewsJan 25th, 2018

Why 2017 Was a Year to Remember for Ionis Pharmaceuticals, Inc.

The RNA-focused biotech had a great year -- even though its share price didn't move much......»»

Category: topSource: foxnewsJan 22nd, 2018

What to Expect From Corbus Pharmaceuticals in 2018

Will the new year bring great results like Corbus had in 2016, or another dismal performance like in 2017?.....»»

Category: topSource: foxnewsDec 20th, 2017

Peregrine Pharmaceuticals Reports Financial Results for Second Quarter of Fiscal Year 2018 and Recent Developments

-- Avid Bioservices Records Revenues of $12.8 Million in t.....»»

Category: earningsSource: benzingaDec 11th, 2017

This Marijuana Stock Is Poised for a Breakout Year in 2018 -- Here"s What You"ll Want to Know About It

GW Pharmaceuticals stock had a sluggish 2017. But just wait 'til next year......»»

Category: topSource: foxnewsDec 2nd, 2017

Polydex Reports Second Quarter Financial Results

TORONTO, Sept. 15, 2017 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC MKTS:POLXF) (the "Company") today announced financial results for the second quarter of the 2018 fiscal year. The three-month and six-month periods ending July 31, 2017 .....»»

Category: earningsSource: benzingaSep 15th, 2017

Peregrine Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018 and Recent Developments

            -- Avid Bioservices Records Revenues of $27 Million in the First Quarter of FY2018 -- -- Roger Lias, Ph.D., Appointed President of Avid Bioservices as Company Continu.....»»

Category: earningsSource: benzingaSep 11th, 2017